RL
Richardson Linda M
Directeur Exécutif
OtherF
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Richardson Linda M, Directeur Exécutif. Officer active across 1 company, notably Intercept Pharmaceuticals, INC.. In total, 15 disclosures have been recorded. Activity tracked since 15 May 2021. The latest transaction was filed on 8 November 2023 (U). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Richardson Linda M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
16,706 shares@ US$19.0070.6% of flowCommon StockSEC:0001104659-23-117112:0
386 shares@ US$21.211.8% of flowCommon StockSEC:0001104659-23-022788:0
12,200 shares0Common StockSEC:0001104659-23-008586:0
1,600 shares@ US$12.374.4% of flowCommon StockSEC:0001104659-23-000335:0
597 shares@ US$18.062.6% of flowCommon StockSEC:0001104659-22-097842:0
124 shares@ US$18.190.5% of flowCommon StockSEC:0001104659-22-092171:0
124 shares@ US$17.882.5% of flowCommon StockSEC:0001104659-22-061928:0
171 shares@ US$15.932.9% of flowCommon StockSEC:0001104659-22-024720:0
529 shares@ US$14.858.2% of flowCommon StockSEC:0001104659-22-023839:0
10,300 shares0Common StockSEC:0001104659-22-009562:0
1,211 shares@ US$16.294.6% of flowCommon StockSEC:0001104659-22-000933:0
171 shares@ US$17.670.7% of flowCommon StockSEC:0001104659-21-140302:0
820 shares@ US$15.052.7% of flowCommon StockSEC:0001104659-21-113043:0
171 shares@ US$14.920.6% of flowCommon StockSEC:0001104659-21-106547:0
171 shares@ US$18.150.7% of flowCommon StockSEC:0001104659-21-068371:0
About Richardson Linda M
Richardson Linda M is Directeur Exécutif and is associated with Intercept Pharmaceuticals, INC. on XNAS as EVP & Chief Commercial Officer. The record shows 15 filings in total, and across the sampled 15 filings the most frequent transaction nature is Tax withholding, with activity dated from 2021-05-17 to 2023-11-13.